The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZOE.L Regulatory News (ZOE)

  • There is currently no data for ZOE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Commencement of trading on the OTCQX

8 Jan 2021 07:00

RNS Number : 9940K
Zoetic International PLC
08 January 2021
 

8 January 2021

 

Zoetic International plc

 

("Zoetic" or the "Company" or the "Group")

 

Commencement of trading on the OTCQX and inclusion in the MSCI Microcap Index

 

Zoetic is pleased to announce that its ordinary shares are now trading on the OTCQX® Best Market in the U.S., under the ticker symbol ZOEIF. The OTCQX® Best Market ("OTCQX") is the highest level of the OTC markets. Zoetic upgraded to OTCQX from the OTCQB® Venture Market.

The OTCQX Market is designed for established, investor-focused U.S. and international companies. To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate governance, and demonstrate compliance with applicable securities laws. Graduating to the OTCQX Market from the OTCQB Market marks an important milestone for companies, enabling them to demonstrate their qualifications and build visibility among U.S. investors.

Zoetic's ordinary shares will continue to trade on the London Stock Exchange under the symbol ZOE. 

In addition to the benefits of the OTCQX Market, the Company is currently evaluating additional opportunities to improve investor relations and communications in North America. The Zoetic directors believe the Company represents a unique opportunity for investors to access a company that is disrupting the tobacco industry with high quality CBD products on an international distribution platform. 

In addition to OTCQX trading, the Company is also pleased to announce that it recently has been included in the MSCI Microcap Index. Inclusion in the index reflects the Company's recent progress in transitioning to a pure play, integrated CBD company and the resultant increase in market capitalisation. The inclusion in the index is another step towards increasing Zoetic's stock liquidity and investment profile in the U.S.

Trevor Taylor, Co-CEO of Zoetic, commented, "The combination of trading on OTCQX and index inclusion reflect the Company's tremendous progress towards transitioning to a pure play, integrated CBD company over the past 12 months. Our recent product development and wholesale distribution expansion have set the stage for the first leg of projected multi-year, sustainable growth for the Company. We couldn't be more pleased with our progress to date, as well as our current position in this high-growth market."

 

**ENDS**

Enquiries

 

Zoetic International plc c/o IFC Advisory

Trevor Taylor, Co-CEO

 

Allenby Capital Limited (Financial Adviser and Broker) +44 (0) 20 3328 5656

Nick Harriss (Corporate Finance)

Nick Naylor (Corporate Finance)

Guy McDougall (Equity Sales)

 

IFC Advisory Ltd (Financial PR and IR) +44 (0) 20 3934 6630

Tim Metcalfe

Graham Herring

Florence Chandler

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDZGGMNNNGMZM
Date   Source Headline
25th Jun 20204:00 pmRNSHolding(s) in Company
24th Jun 20203:00 pmRNSHolding(s) in Company
22nd Jun 20207:00 amRNSHolding(s) in Company
15th Jun 20207:00 amRNSHolding(s) in Company
3rd Jun 20209:05 amRNSSecond Price Monitoring Extn
3rd Jun 20209:00 amRNSPrice Monitoring Extension
2nd Jun 20207:00 amRNSSubscription for Equity
1st Jun 20207:00 amRNSNew Distribution Agreement and Trading Update
29th May 20207:00 amRNSFiling of Patents
27th May 20207:00 amRNSSale of DTU Interest and Kansas Nitrogen Assets
15th May 20207:00 amRNSTrading Update
11th May 20203:36 pmRNSHolding(s) in Company
6th May 20202:34 pmRNSHolding(s) in Company
29th Apr 20207:00 amRNSBoard and Strategy Changes, and Trading Update
3rd Apr 20207:00 amRNSIssue of Equity
1st Apr 20207:00 amRNSCOVID-19 Update
26th Mar 202011:05 amRNSSecond Price Monitoring Extn
26th Mar 202011:00 amRNSPrice Monitoring Extension
26th Mar 20207:00 amRNSIssue of Equity
20th Mar 20207:00 amRNSCOVID-19 Update
5th Mar 20207:00 amRNSOperational update
12th Feb 20207:00 amRNSSubscription to raise £0.39 million
5th Feb 20207:00 amRNSTrading Update
23rd Dec 20197:00 amRNSInterim Results
16th Dec 20197:00 amRNSSettlement of Diversion Debt & Notice of Results
28th Nov 20197:00 amRNSResult of General Meeting
25th Nov 20197:00 amRNSTrading Update
14th Nov 20199:19 amRNSIssue of Equity
13th Nov 20192:06 pmRNSSecond Price Monitoring Extn
13th Nov 20192:00 pmRNSPrice Monitoring Extension
11th Nov 20197:00 amRNSListing on the OTC
8th Nov 20199:01 amRNSIssue of Equity
7th Nov 20197:00 amRNSNotice of General Meeting
1st Nov 20192:05 pmRNSSecond Price Monitoring Extn
1st Nov 20192:00 pmRNSPrice Monitoring Extension
29th Oct 20194:42 pmRNSSecond Price Monitoring Extn
29th Oct 20194:35 pmRNSPrice Monitoring Extension
21st Oct 20197:00 amRNSIssue of Shares
18th Oct 201911:05 amRNSSecond Price Monitoring Extn
18th Oct 201911:00 amRNSPrice Monitoring Extension
8th Oct 20197:00 amRNSAdoption of new share option scheme
4th Oct 20197:00 amRNSTrading Update
17th Sep 20197:00 amRNSDirectorate Change
12th Sep 201912:30 pmRNSDirector/PDMR Shareholding
9th Sep 201911:15 amRNSChange of Name
6th Sep 201910:30 amRNSDirector/PDMR Shareholding
4th Sep 201911:05 amRNSSecond Price Monitoring Extn
4th Sep 201911:00 amRNSPrice Monitoring Extension
4th Sep 20197:00 amRNSDirectorate Change
30th Aug 20194:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.